17:12 IST
NSE
Results Update
Aarti Drugs Results Update
Aarti Drugs reported Q1 FY27 consolidated revenue of ₹703.6 crore and EBITDA of ₹96.9 crore, reflecting 19% and 30% YoY growth respectively.
Aarti Drugs Ltd
- Share price
- ₹428.80
- Market cap
- ₹3,914 Cr
- Revenue (annual)
- ₹2,565 Cr
- Net profit (annual)
- ₹194.9 Cr
- P/E (TTM)
- 20.5×Sector 47.4×
- Promoter holding
- 54.43%-0.60% QoQ
- FII holding
- 1.52%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Earnings Call 6Other Announcement 4Legal & Regulatory 3Board Meeting Date 3Results Update 2Management Change 2Financial Results 2Annual General Meeting 2Share Pledge 1Promoter Selling 1Employee Stock Options 1Board Meeting Outcome 1Annual Report 1Adverse Business Impact 1
Time
2 announcements with these filters
14:33 IST
NSE
Results Update
Aarti Drugs Results Update
Aarti Drugs reported FY26 revenue of ₹2,567.7 Crore, reflecting 7% year-on-year growth. Net profit reached ₹194.9 Crore, driven by strong sequential recovery and operational scale-up.
- Value
- ₹2,568 Cr